Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies

The age-related macular degeneration (AMD) field is witnessing promising advancements in therapeutic options. Breakthrough drugs such as pegcetacoplan and avacincaptad have been FDA-approved for dry AMD, marking a significant development as there were no treatment options until August 2023. While se...

Full description

Saved in:
Bibliographic Details
Main Authors: Audrey Yan, Nasiq Hasan, Jay Chhablani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:https://journals.lww.com/10.4103/IJO.IJO_1120_24
Tags: Add Tag
No Tags, Be the first to tag this record!